📑Achizitie medicamente Program PNS3 Oncologie - Ambulatoriul de specialitate
Procurement process summary
This process is to purchase Achizitie medicamente Program PNS3 Oncologie - Ambulatoriul de specialitate.
This contract was awarded by 🇷🇴 ACTAVIS S.R.L. for an amount of RON 215,637 to 1 supplier. It was published on 2011-12-21 through limited
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇷🇴 ACTAVIS S.R.L. Buying unitnot reported Publication date2011-12-21 Contest statusnot reported Descriptionachizitie medicamente Program PNS3 Oncologie - Ambulatoriul de specialitateAwards
This award was granted to MEDIPLUS EXIM S.R.L. by ACTAVIS S.R.L. for an amount of RON 215,637. The procurement process was conducted through limited for the category of goods. This is award number 1.
| Supplier | Amount | Award number |
|---|---|---|
| 🇷🇴 MEDIPLUS EXIM S.R.L. | RON 215,637 | 1 |
Market context and opportunities
The execution of this contract allows the entity ACTAVIS S.R.L. to fulfill its public service objectives efficiently.
The limited purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberRO_ocds-70d2nz-41af6289-5f5e-4d13-acb6-d20453bae669-award-1Publication date2011-12-21Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalitylimitedMethod detailsCerere de ofertaStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
